1. Home
  2. HOOK

HOOK

HOOKIPA Pharma Inc.

Logo HOOKIPA Pharma Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Founded: 2011 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 72.5M IPO Year: 2019
Target Price: $4.44 AVG Volume (30 days): 538.8K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.86 EPS Growth: N/A
52 Week Low/High: $0.41 - $2.05 Next Earning Date: 05-09-2024
Revenue: $20,129,000 Revenue Growth: 41.27%
Revenue Growth (this year): 66.71% Revenue Growth (next year): -54.62%

Share on Social Networks: